Biomedical, Clinical & Life Sciences

Global Reach II

No applicants // Limit: 1 // Tickets Available: 1 

 

This notice announces the opportunity to apply for funding under the Global Reach II Program. The purpose of this initiative is to collaboratively formulate and deliver high quality solutions across the range of programming required to achieve sustainable HIV epidemic control as guided by the Office of the Global AIDS Coordinator of the U.S. State Department, emphasizing new and innovative approaches pursued jointly with HRSA and other stakeholders. An additional purpose is to assist with translating new science into programming and to mitigate the impact of forces such as global pandemics in the HIV response. Programs and activities are to span health services, structural interventions, and data use and tracking systems. Global Reach  encompasses four major categories of support: 1. HIV Direct Service Delivery 2. Human Resources for Health 3. Quality Improvement 4. Health Systems Strengthening. Global Reach II will also leverage HRSA’s broader expertise and equities on global health needs.

No applicants.

Funding Type
Internal Deadline
External Deadline
07/21/2021

2021 Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90 Independent Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The National Institute of Dental and Craniofacial Research (NIDCR) will award Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90) to eligible, domestic institutions to enhance predoctoral and postdoctoral research training for Ruth L. Kirschstein National Research Service Award (NRSA) eligible trainees (T90) and postdoctoral research education (R90) for eligible dentist scientists to ensure that a diverse and highly qualified workforce is available to address the Nation's biomedical, behavioral and clinical research agenda.

No applicants.

Internal Deadline
External Deadline
09/27/2021

Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this program is to foster the next generation of global health scientists by providing trainees, early in their careers, a one-year mentored research training experience in global health at established biomedical and behavioral research institutions and project sites in LMICs. The focus of this FOA is on U.S. and LMIC post-doctoral and U.S. pre-doctoral trainees.

No applicants.

Internal Deadline
External Deadline
08/20/2021

2022 Searle Scholars Program

UArizona is invited to submit one nomination.

Applicants for the 2022 competition (awards which will be activated on July 1, 2022) are expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences.

Applicants should have begun their appointment as an independent investigator at the assistant professor level on or after July 1, 2020. The appointment must be their first tenure-track position (or its nearest equivalent) at an invited institution.

S. Doroudgar

Internal Deadline
External Deadline
09/30/2021
Solicitation Type

2021 Beckman Young Investigators

UArizona may submit more than one application; however, the LOI process is Institutionally Coordinated.

For PIs interested in submitting a Letter of Intent (LOI) to the Beckman Young Investigators Program (BYI), please follow the steps below and e-mail the LOI to Sponsored Projects & Contracting Services (SPCS) by Monday, July 26th, 2021, for Institutional Endorsement from the Chief Academic Officer.

  • Principal Investigator (PI) completes the Online Application, uploads all required documentation
  • The PI or their Department creates a complete, single PDF of the LOI, including content printed from the Beckman application portal after Dean’s endorsement and all uploaded attachments. Forward the single PDF via e-mail to sponsor@email.arizona.edu with the subject "Beckman Young Investigator LOI for Endorsement." Redact sensitive information (like social security numbers) as needed.
  • SPCS Proposal Services verifies LOI content and will contact eligible PIs and/or their Department by July 27th with instructions to proceed with Chief Academic Officer endorsement.
  • The Chief Academic Officer (Provost) will only endorse applications verified by SPCS as complete and eligible by the July 26th deadline.  SPCS Proposal Services will coordinate as needed with the Office of the Provost.

Please do not enter an email address for Chief Academic Officer endorsement until you have approval from SPCS Proposal Services.

Please do not contact the Office of the Provost directly regarding endorsements but communicate through Sponsored Projects & Contracting Services at sponsor@email.arizona.edu or (520) 626-6000. SPCS will work as quickly as possible to ensure they are all reviewed and endorsed by the sponsor deadline. See the Beckman Young Investigators Program website for an overview video and eligibility requirements.

Internal Deadline
External Deadline
08/02/2021

2021 NIH Director's Early Independence Awards (DP5 Clinical Trial Optional)

No applicants // Limit: 2 // Tickets Available: 2 

 

The NIH Director's Early Independence Award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

T. Sawyer
E. Blackwood

Internal Deadline
External Deadline
09/03/2021

Clinical and Translational Science Award (U54 Clinical Trial Optional) July 2021 (CTSA)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this funding opportunity announcement (FOA) is to invite applications to participate in the Clinical and Translational Science Award (CTSA) Program which supports high quality translational science and clinical research locally, regionally and nationally and fosters innovation in research methods, training, and career development.

No applicants.

Internal Deadline
External Deadline
07/15/2021

Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research

No applicants // Limit: 1 // Tickets Available: 1 

 

The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the area of the prevention of coronary heart disease or circulatory failure, and improving care for these patients. The Program focuses on basic and translational scientific research. Clinical studies are currently ineligible.

Eligibility: Each invited institution may submit a single application from a full-time faculty member. United States citizenship is not required. Junior faculty and those with less than $500,000 in direct costs funding at the time of application are encouraged to apply.

No applicants.

Internal Deadline
External Deadline
07/15/2021
Solicitation Type